We consider conditional estimation in two-stage sample size adjustable designs and the following bias. More specifically, we consider a design which permits raising the sample size when interim results look rather promising, and, which keeps the originally planned sample size when results look very promising. The estimation procedures reported comprise the unconditional maximum likelihood, the conditionally unbiased Rao-Blackwell estimator, the conditional median unbiased estimator, and the conditional maximum likelihood with and without bias correction. We compare these estimators based on analytical results and by a simulation study. We show in a real clinical trial setting how they can be applied.
Introduction
Adaptive design has made its way into the repertoire of practical clinical biostatistics as shown by the discussion [10] as well as the fact that European and US guidance documents for the use of adaptive designs in clinical trials had been developed. Adaptive designs are applied in the confirmatory context (Phase III) as well as in earlier development. For example, recently adaptive Phase II or seamless Phase II/III case studies have been described [19, 8] .
In this article, we consider recalculation of the sample size based on an interim effect estimate. For this adaptive design, statistically valid methods are required for inference. Much work has been done in the past decades to provide significance tests which adequatly control the type I error rate in the context of sample size recalculation. For example, conditions have been identified [24, 5, 18, 2] where the conventional significance test (which would be done in a non-adaptive situation) is still valid after sample size recalculation in controlling the type I error rate. In these references, the general conditional error approach is applied which says that adaptations are allowed as long as the conditional error rate of the final test does not increase by the adaptation, see [20, 21] . Alternatively, if it is not desired to adhere to these conditions, several good methods exist indicating how modified significance tests can be performed in this adaptive setting with type I error rate control.
However, point and interval estimates are usually of high importance for clinical interpretation of trial results. Therefore it has been identified that inference in adaptive designs needs to focus more on estimation.
The current article will discuss the implications for bias and variance of parameter estimates in scenarios involving two-stage adaptive designs with sample size recalculation. Especially, we will consider conditional inference. [14] exhibit conditionally unbiased estimators for the case of a study with possible futility stop. [13] have for a multi-arm study considered additionally the possibility to remove some of the treatments in an interim analysis. The reference [17] derives conditional maximum likelihood estimators in a group sequential setting.
For the case of a two-stage adaptive design with sample size recalculation, we will develop here conditional estimation methods: the conditionally unbiased Rao-Blackwell estimator, the conditional median unbiased estimator, and the conditional maximum likelihood with and without bias correction.
We compare these estimators and the unconditional maximum likelihood estimator based on analytical results and by a simulation study.
For a previously conducted randomized controlled clinical trial which investigated a treatment for schizophrenia patients, we show how the considered estimators can be applied. In this example we show also that our investigations can be applied in contexts which seem slightly different to those formally discussed.
In this article, we will consider the case of normally distributed data with known variance. In Section 2, we provide the general assumptions and the considered sample size recalculation rule, discuss bias of the conventional maximum likelihood estimate (MLE) and mention unconditionally unbiased estimates. In Section 3, we derive several conditional estimators and compare them algebraically. In Section 4, we compare the estimators in a simulation study, show the clinical trial application in Section 5 and conclude with a discussion in Section 6.
Background

General setting and bias
We consider the one-sample case with independent normally distributed observations. Let the observations be
2 ) with σ 2 known. An interim analysis is performed after n 1 observations (Stage 1) and based on the results, the sample size N 2 for Stage 2 is determined; the total sample size is N = n 1 + N 2 (note that N 2 and N are random variables). We use the simplified notation
represents the additional information collected after the interim analysis, σ 2 = σ/ √ N 2 . A more general set-up, including two-arm parallel group studies with known common variance and observations {(X 1,1 , . . . , X 1,n ), (X 2,1 , . . . , X 2,n )}, is touched upon in the Discussion. For now, please note that forming paired differences X i = X 1,i − X 2,i will turn that design into the present set-up.
In a study with the aim to test H 0 : µ = 0 versus H 1 : µ > 0, the parameter µ should be estimated by aμ after all N observations. The mean of all observations is the unconditional maximum likelihood estimate (MLE) for µ. Therefore, we writeμ ML = Y = To choose the 2nd stage sample size N 2 = N 2 (Y 1 ) as decreasing function of Y 1 > 0 is a natural choice as larger sample sizes are needed if the true µ > 0 is small. If one applies equal weight to all observations inμ W M,w , i.e. w(Y 1 ) = n 1 /(n 1 + N 2 (Y 1 )), the result of [1] shows therefore thatμ W M,w overestimates µ under µ > 0.
In this paper, we consider the following design: We decide in the interim analysis to stop for futility if the observed effect is low (decision R = 0 and final sample size n f ≥ n 1 ), to continue to an increased maximal sample size n max if the observed effect is promising (decision R = 1) or to continue with a planned, original sample size n 0 if the observed effect is very promising (decision R = 2), n 1 ≤ n 0 < n max . We summarize the decision R and sample size N based on the observed effect Y 1 as follows:
for some constants c 1 , c 2 with −∞ ≤ c 1 < c 2 ≤ ∞. Usually n f = n 1 is desired but sometimes this is not possible in practice and an "overrun" n f > n 1 needs to be accepted. Note that a common two-stage group sequential design without sample size recalculation is an important special case of (1) with n f = n 0 = n 1 (or allowing overrun with n f = n 0 ≥ n 1 ). In the design defined through (1), we may calculate the bias ofμ W M,w with w( For example for n 1 = 50, n 0 = 100, n max = 150 and for σ = 1, the bias ofμ W M,w in dependence of µ is shown in Figure 1 for some choices of (c 1 , c 2 ). The bias is negative around the value c 1 (where the sample size increases from Y 1 < c 1 to Y 1 > c 1 ) and is positive around c 2 (where the sample size decreases from
. When c 1 and c 2 are very close (e.g. c 1 = 1, c 2 = 1.1, lower right panel), the positive bias can almost be hidden by the overlying negative bias.
Unconditionally unbiased estimates of the treatment effect
We can search for estimatesμ which are unbiased in the traditional, unconditional sense, i.e. E[μ] = µ, by choosing appropriate weight functions w(Y 1 ) forμ W M,w . When the trial cannot stop at the interim, i.e. c 1 = −∞, n max , n 0 > n 1 , then any predetermined weights w(Y 1 ) = w 1 and 1 − w 1 ,
will ensure an unbiased estimate. According to [4] , weights defined by w 1 = 2n 1 /(n 0 + n max ) may work fine. When early stopping is permitted, the reference [15] presents the unbiased estimatê
for predetermined weights w 1 , w 2 , suggested to be w 1 = n 1 /n 0 and w 2 = 1 − w 2 1 . In the sequel, we will not restrict ourselves to predetermined weights and will permit that the weights change due to adaptations.
Conditional estimation after sample size recalculation
If the consequences of bias are different depending on the interim decision R, conditional estimation is sensible. In studies with an interim decision about futility stop only (c 2 = ∞, i.e. R ∈ {0, 1}), it is reasonable to require unbiasedness specifically if the trial is continued to Stage 2 (R = 1). Only if not stopped for futility, the results are used by regulatory agencies for decisions about licensing or if a Phase II trial is considered by the sponsor for decisions about continuation of the program to Phase III. Therefore, it is argued in [22] to require unbiasedness under the condition that the trial is continued,
However, in our situation with decision rule (1), i.e. when based on an observed large effect the study is continued to a smaller sample size or stopped directly, the situation is a bit more complex. The interesting situations when good properties of the estimators are required are both R = 1 as well as R = 2. We investigate therefore the bias under the condition of R and show how to make the analysis unbiased in the conditional setting. As discussed before, the cases R = 1 and R = 2 are of main interest and we consider therefore these cases and not R = 0 in the sequel.
Uniformly Minimum Variance Unbiased Estimation
Consider first R = 2. Following the reference [13] , which builds on [6] , one may by means of the RaoBlackwell theorem find an Unbiased Minimum Variance Estimate conditional on proceding to stage two. There the situation is a drop-loser design, where the sample size of the second stage is given. In such a drop-loser design one would go forth to the second stage with selecting the best treatment and drop the others. In this article, however, we will derive results for only one treatment arm, thus without selection, and without control.
In contrast to the drop-the-looser situation with fixed sample sizes, we consider here a simple version of sample size re-calculation.
The conditional bias of the unconditional MLEμ ML equals
whereb i =b i (µ) = (µ − c i )/σ 1 , i = 1, 2, cf. (13.133) and (13.134) in [12] . However, since µ is unknown we cannot calculate this bias in practice. There is another way to construct an unbiased estimator which builds on the Rao-Blackwell theorem.
In the following Theorem, we present the Uniformly Minimum Variance Conditionally Unbiased Estimator (UMVCUE) and its conditional variance. The estimator consists of two terms: the unconditional MLEμ ML and a product of a standard deviation and a ratio involving φ and Φ, which is in the case of R = 2 equal to the inverse Mills ratio ν(x) = φ(x)/Φ(x). The unbiasedness is achieved by subtracting a term which closely resembles the bias presented above. The proof can be found in the Appendix Theorem: The Uniformly Minimum Variance Conditionally Unbiased Estimator (UMVCUE)μ RB is given byμ
where ∆φ = φ(
The conditional variance is given by:
where
and the variance factors in (4) can be found in the proof in formulae (13) and (14) . Note that the values of σ 2 , σ A , σ B are different for case R = 1 and R = 2 since they depend on N 2 . To illustrate the difference between the Rao-Blackwell estimate in the above theorem and the Maximum Likelihood estimate, we showμ RB −μ ML versus the MLEμ ML for R = 1 and R = 2, see Figure  2 , with the specific values n 1 = 50, n 0 = 100, n max = 150, c 1 = 0.9, c 2 = 1.2 and σ = 1. For example let us look at R = 1, i.e. when we have 0.9 < Y 1 < 1.2 for the interim mean. Then the total sample size is raised from n 0 = 100 to n max = 150. If the final mean,μ ML , is still between 0.9 and 1.2, the MLE and the Rao-Blackwell differ at most 0.05. Ifμ ML > 1.2, then the Rao-Blackwell estimate is larger than the MLE and ifμ ML < 0.9, then the Rao-Blackwell estimate is smaller than the MLE; this means in both cases thatμ RB is shrunken towards Y 2 .
The fact thatμ RB −μ ML vs.μ ML is monotonically increasing for R = 1 and R = 2 implies that the Rao-Blackwell estimator overweights the second stage data compared to the first stage data. This is, if we define
In Figure 2 for R = 1,μ RB −μ ML > 0 if and only ifμ ML > 1.05. Note that 1.05 is the mean of c 1 and c 2 . Further we recognize thatμ RB −μ ML < 0 for R = 2. It follows from (3) that this observation is valid in general, see the following corollary: 
, see the proof of the above Theorem.
Conditional Median Unbiased Estimation
The conditional median unbiased estimation comes naturally from interval estimation based on solving the equation
with respect to µ for q = 0.5, cf. [14] and [25] . The solution µ of (5) is the conditional median unbiased estimator and will be denoted byμ CMU . Note that interval estimation can be achieved by solving for q 1 and q 2 with q 2 > 0.5 > q 1 such that q 2 − q 1 = l is the desired confidence level. Take the case R = 1 first. As in the derivation of the Rao-Blackwell estimator we may show that the joint density for Y 1 and Y under the condition can be written as
with a functionk(µ) independent of y 1 and y. Integrating out y 1 yields the conditional density:
see also (13.133) in [12] . From this the case R = 2 follows:
cf. equation (2) in [14] . We obtain a similar result when we compareμ CMU andμ ML as we have obtained for the comparison ofμ RB andμ ML in Section 3.1.
Theorem:
If R = 2 thenμ CMU <μ ML . Proof: Instead of (5), we can solve
f (y|µ, R)dy (both integrals will be 0.5, then). Consequently,μ CMU is the solution µ of
with h(y) = Φ c2−y σA
2 , it follows from (6) that the normal density needs to have its mean at needs to upweight the interval (−∞,μ ML ] in order to fulfill (6) . We obtainμ CMU <μ ML .
Building on [14] one may derive an approximate bias formula forμ CMU . Using equation (8) in [14] we may write
To denote the conditional expectation ofμ ML use the notation µ R = µ + bias ML (µ, R), where the bias is specified in equation (2) . This means that the bias approximately equals
For R = 1, the derivative equals
Then evaluate at x = µ 1 , with µ 1 = µ + bias ML (µ, 1), and similarly for R = 2. The Delta Method provides an estimate of the variance through
In the scenarios tested however, approximation (7) appears rather inaccurate, see Section 4.
Conditional Maximum Likelihood Estimation
The reference [17] addresses conditional maximum likelihood estimation in a group sequential setting with efficacy stopping, and treats the problem with bivariate observations. Here, instead, we permit two kinds of continuation to the second stage, either with or without sample size adjustment, and, we derive an explicit bias correction formula. We will derive the likelihood function given R = 1. For this we write
The likelihood function is the product of a constrained multivariate distribution (for Stage 1) and an unconstrained (for Stage 2):
Then the log likelihood becomes
Taking the derivative L ′ R (µ) =
∂LR(µ) ∂µ
with respect to µ and using b
Note that the last term of L ′ R (µ) equals −N × bias ML (µ, R)/σ 2 , and, that the expected value of the first is N × bias
, cf. Lemma 6.1 of [16] . Solving the optimality condition
with respect to µ yields the conditional maximum likelihood estimateμ CML . An estimate of the variance of the estimator may be obtained through the observed information j
The variance estimate is −j(μ CML ) −1 . In cases where asymptotics do not seem applicable a bootstrap approach offers an alternative. Also, a likelihood based confidence interval employing a χ
As explained in [7] the bias of the MLE is related to the first three derivatives of the log likelihood.
The formula (5.26) of [7] implies that the bias equals
Please note that the second and third derivatives are independent of the sample. Further, as the expectation of the first derivative equals 0, the bias formula simplifies to
The above extends in an obvious way to any one-parameter MLEθ(X), estimating an unknown parameter θ, noting that
The case R = 2 follows when c 2 → ∞ and then with c 2 replacing c 1 .
A bias corrected estimateμ CMLc comes from solving the equation
with respect to µ, cf. equation (5.6.1) in [25] . We also tested the corrected estimateμ CMLc =μ CML − bias CML (μ CML , R), but the results were almost identical (data not shown).
If R = 2 thenμ CML <μ ML . Proof: Since the derivative in equation (10) equals zero at the optimum it follows that
from which the case R = 1 is immediate, noting that the denominator is positive, and, that:
Difference between conditional estimators
We have seen empirically and proven algebraically that for all conditional estimatorsμ ∈ {μ RB ,μ CMU , µ CML }, the estimate is smaller thanμ ML if R = 1 andμ ML < c1+c2 2 or if R = 2 and it is larger than
Based on numerical investigations, we investigate now the difference between the conditional estimators,μ RB ,μ CMU ,μ CML ,μ CMLc . Figure 3 shows the difference for n 1 = 50, n 0 = 100, n max = 150, c 1 = 0.9, c 2 = 1.2, σ = 1. The largest difference in this scenario betweenμ CMU andμ RB is for R = 2 and µ ML ≈ 1.32 and is −0.0066. Compared to the difference betweenμ RB andμ ML seen before ( Figure  2 ), this is a quite small difference. The difference betweenμ CML andμ RB is a little larger but still at most 0.01. We see that we can order the estimators in terms of how much they correct the ML: µ RB ,μ CMU ,μ CML (from smaller to larger absolute difference to ML). When we correctμ CML for the bias, the resultingμ CMLc is very similar toμ RB .
When analysing numerically the difference between estimators for other scenarios, we have seen that this difference is often small. The estimators differ slightly more for smaller sample sizes and especially if n 0 − n 1 and n max − n 0 become smaller. 
Simulation study
To assess the various methods we simulated normal data corresponding to a number scenarios and replicated a large number of times (1000,000). In each replication the outcome of Y 1 defined R and thereby decided the final design according to formula (1) . Without loss of generality the value of σ was held fix at 1. We fixed also the value c 1 = 0.9 as the results depend only on the differences between the values for µ, c 1 and c 2 . We varied then µ over {0.9, 1, 1.2, 1.4} and c 2 over {1.2, 1.3}. The maximal patient number (used when R = 1) was defined as n max = 150 throughout, and n 0 was set to n 1 + 50, while n 1 varied over {50, 70}. These scenarios are presented in Table 1 .
In Table 1 the methods are denoted as follows: Rao-Blackwell (RB), conditional median unbiased (CMU), conditional MLE (CML), bias corrected conditional MLE (CMLc), unconditional MLE (ML). In the simulations the CMLc used the correction bias(μ|R) from equations (11) and (12) . The tables provide the observed bias, variance and mean-square error (MSE) conditional on R = 1 and R = 2 as well as the number N of replications with R = 1 and R = 2, respectively.
Among the methods there is a high degree of concordance. From a practical point of view one could argue that MSE should take precedence over both bias and variance. As judged by MSE the methods RB, CMU, CML, and CMLc perform equally well. If we require strict conditional unbiasedness, then of course Rao-Blackwell is the only option.
However, one may argue that the naive unconditional MLE does quite well. In particular under R = 1, it performs best. If the true mean µ is large (≥ c 2 , i.e. R = 2 is likely), the MLE performs also well under R = 2 (see second and third scenario in Table 1 ). In the cases when µ is small (≤ c 1 , i.e. R = 2 is unlikely) but anyway R = 2 happened, the conditional MSE of the MLE is larger than for the other estimators (see first and last scenario in Table 1 ). Note that R = 2 happened in 8% and 2% of the simulations in these two scenarios, respectively.
The simulated bias in Table 1 can be compared with the theoretical biases stemming from (2), (7) and (11) . The theoretical bias from (2) for ML coincides up to the third decimal with the simulated values in all cases. Also for CML, the simulated biases reflect the theoretically expected outcomes from (11) quite well with most absolute differences ≤ 0.001 and all ≤ 0.002 except the last scenario for R = 2 (simulated bias= −0.005; theoretical approximation= −0.001). In contrast, the approximation (7) appears more inaccurate. For example, the discrepancy in the second scenario in Table 1 (µ = 1.2, n 1 = 70, c 2 = 1.2) for R = 2 is 0.011 (simulated bias= −0.007; theoretical approximation= 0.004). It is generally common that the simulated and theoretical bias have different signs.
Application in a schizophrenia trial
In a randomized, double-blind trial for clinically stable patients with schizophrenia, the treatments quetiapine and placebo were compared, [23] . The primary endpoint was time to first schizophrenic relapse analyzed by a Cox proportional hazards model. An interim analysis was conducted after 45 relapses observed (totally in both treatment groups) and the final analysis was scheduled after 90 relapses. (We ignore here for now the second interim which was preplanned -we will discuss this below.) We apply normal approximation to the survival analysis data and the total number of relapses are treated as sample size.
The trial was preplanned to be stopped when the interim two-sided p-value was < 0.004455, i.e. stop for efficacy if p < 0.004455 to the advantage of quetiapine, and stop for futility if p < 0.004455 to the advantage of placebo. The trial had a fast recruitment speed and therefore, 61 relapses had been observed when the independent Data and Safety Monitoring Board's recommendation "stop" or "continue" from the interim analysis could be announced. The number of 61 relapses was not preplanned; nevertheless, we treat here the increase to 61 relapses as an unavoidable consequence of the recruitment process, like it would have been fixed in advance to have 61 relapses at this time.
When applying normal approximation (see Chapter 3.4 in [25] or Chapter 3.7 in [11] ), we can formulate this situation with our sample size rule (1) with n 1 = 45, n 0 = 61, n max = 90. The normal approximation implies that − log(ĤR) ∼ N (− log(HR), 4/n) and therefore in accordance with our notation from Section 2, we have variance σ 2 = 4. We obtain c 2 = σ 2 /n 1 Φ −1 (1 − 0.004455/2) = 0.848, c 1 = −c 2 = −0.848. According to [23] , the observed hazard ratio was 0.16 after 45 relapses and 0.13 after 61 relapses. Taking − log(ĤR), we have Y 1 = 1.83 in the interim andμ ML = 2.04 in the final analysis. In order to compute the Rao-Blackwell and conditional median unbiased estimator, we compute first 
Computing the other conditional estimates shows that in this case with a very clear result andμ ML far from c 2 , the estimatesμ CMU ,μ CML ,μ CMLc are almost equal toμ ML . Let us assume that in contrast to the true trial results, the interim analysis would have just been over the stopping boundary with an estimated hazard ratio of 0.42 and that after 61 relapses the same estimate was obtained (Y 1 =μ ML = 0.87). We obtain hereμ RB =μ ML − 0.304 = 0.566 which corresponds to a Rao-Blackwell estimated hazard ratio of exp(−0.566) = 0.57. The estimated hazard ratios with CMU, CML and CMLc are 0.59, 0.60, 0.57, respectively.
In this clinical trial, the result was a stop after interim, R = 2, and we condition on this outcome in the analysis. Therefore it does not matter for the conditional estimates how the design of the study would have been if R = 1 would have occured. The above calculated estimates are therefore valid even for the real situation where a second interim analysis was preplanned.
Discussion
The naive MLE performs well in the simulations presented here. When comparing the unconditional MLE used in the conditional setting with the conditional estimators, the former had in many but not in all scenarios smaller MSE. However the unconditional MLE does not possess any optimality features in the conditional inference setting. Therefore it is worth while searching for alternatives that satisfy certain optimality criteria relevant for the conditional inference. The difference between the four conditional estimators was quite small in the scenarios considered. This was reflected also in terms of their bias (they had no bias or very small bias) and their variance which was similar. It is therefore not of main importance which of these to choose. The conditional Rao-Blackwell estimator has the advantage that it is unbiased by construction and has an explicit representation making computation simpler.
In this paper, we considered a sample size rule with general boundaries c 1 < c 2 . In practice, one can choose these boundaries c 1 and c 2 to achieve a certan conditional or predictive power (see e.g. [11] , ch. 10). Besides of considering these statistical criteria, we suggest to take non-statistical views into consideration: Usually an independent committee performs the interim analysis and recommends sample size for Stage 2 (or futility stop). The constants should then be chosen in order to mimic an anticipated way of reasoning of the committee (e.g. due to ethical arguments). Further, the decisions should be reasonable from an investment perspective. If these ethical and business arguments can be quantitatively specified, an optimisation of c 1 and c 2 might be an option. We refer to future research with regard to decision theoretic optimisation in this context and to a recent review article, [9] , about decision theoretic methods in small studies.
It is straightforward to generalize our methods to a sample size rule with more steps, e.g. constant sample sizes between three cut-points c 1 , c 2 , c 3 . However, if an increasing number of cut-points are introduced, we will condition on more and more information from Stage 1. In the extreme case (for a continuous sample size recalculation formula) one would condition on the interim observation Y 1 . This would imply that the UMVCUE will beμ RB = Y 2 as mentioned in Section 3.1. [3] discuss the fact that the information from Stage 1 is no longer used for the conditional estimate.
We point out that the methods described in this paper require the prespecification of the sample size recalculation rule. A further limitation of this elaboration is that we assumed known variance. In practice, variance is not known and one would use our methods with estimated variance. In this case the observed mean values are t-rather than normal-distributed. More generally, alternatives to our assumption of normally distributed data might be considered in future research. However, recall that we have pointed out ways to generalize to other one-parameter-families of distributions in Section 3.3. Further, if the sample sizes are large, the stagewise means are approximately normally distributed. Therefore we could apply our methods to the schizophrenia trial with a survival endpoint.
One may further extend our results concerning the one-arm model to two arms by use of profile likelihood. In a parallel group study the estimation problem may be expressed as follows, cf. [25] . The two independent series of observations obey laws f (x, µ 1 , η) and f (x, µ 2 , η), respectively, where η is a vector of common nuisance parameters. The parameter of interest is the contrast θ = The case R = 2 can be treated as special case of R = 1 by setting c 2 = ∞ and replacing c 1 by c 2 leading toμ RB = y − σ B φ(z2) Φ(z2) . See also [13] for the case R = 2. The conditional variance ofμ RB may be obtained through the Delta Method, cf. [14] . For R = 1, the approximate conditional variance follows from application of that method by writingμ RB as a function of y, g 1 (y) = y − σ B φ(z 1 (y)) − φ(z 2 (y)) Φ(z 1 (y)) − Φ(z 2 (y)) .
